Juliessa M. Pavon

Nov 29, 2024 | agsjournals.onlinelibrary.wiley.com | Sascha Dublin |Juliessa M. Pavon |S. Nicole Hastings |Ladia Albertson-Junkans

CONFLICT OF INTEREST STATEMENT SD has received funding from GSK. SH has consulted for or received funding from Pfizer, Johnson & Johnson, Novo Nordisk, Arbor Pharmaceuticals, the Medullary Thyroid Cancer Consortium (Novo Nordisk, AstraZeneca, GlaxoSmithKline, and Eli Lilly), Biogen, Intercept Pharmaceuticals, Provention Bio, bluebird bio, and Amylyx Pharmaceuticals.

Jun 3, 2024 | agsjournals.onlinelibrary.wiley.com | Anna Hung |Lauren Wilson |Valerie Smith |Juliessa M. Pavon

CONFLICT OF INTEREST STATEMENT AH reports honoraria and conference support from Academy of Managed Care Pharmacy, honoraria from Journal of Managed Care and Specialty Pharmacy, conference registration from Pharmacy Quality Alliance, and research grants from Abbott and AstraZeneca. MLM reports ownership of Amgen stock due to his spouse's employment. No other authors report conflicts.

Jun 3, 2024 | agsjournals.onlinelibrary.wiley.com | Juliessa M. Pavon |Audrey D. Zhang |Laura Fish |Margaret Falkovic

CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest. Supporting Information Filename Description jgs19011-sup-0001-supinfo.pdfPDF document, 337.1 KB Supplementary Table S1. COREQ (COnsolidated criteria for REporting Qualitative research) checklist. Supplementary Text S2. Additional detail on methods. Supplementary Text S3. Interview guide for hospitalized patients. Supplementary Text S4. Interview guide for hospital providers. Supplementary Text S5.

May 7, 2024 | bmj.com | Anna Hung |Yoon Kim |Juliessa M. Pavon |Co-first authors

State of the Art Reviews are commissioned on the basis of their relevance to academics and specialists in the US and internationally. For this reason they are written predominantly by US authors. Funding: AH is supported by VA HSR&D (Career Development Award IK2 HX003359) and by the US Deprescribing Research Network (R24AG064025). JMP is supported by a Career Development Award K23AG058788 from the National Institute on Aging.

May 3, 2024 | jamanetwork.com | Anna Hung |Lauren Wilson |Valerie Smith |Juliessa M. Pavon

Key PointsQuestion  How did US nationwide comprehensive medication review (CMR) completion rates and disparities change after implementation of a 2016 Medicare Star Rating quality measure? Findings  This observational study of 561 950 Medicare beneficiaries using interrupted time-series analysis found that CMR completion rates increased in part due to plans reducing the size of the medication therapy management–eligible population by redefining their eligibility criteria.